Barbara Zemann

Barbara Zemann is a Senior Director of Preclinical Development at AOP Health, a position held since April 2019, and serves as the preclinical development lead. Prior to this, Barbara worked as a non-clinical consultant at The NCD Company from February 2019 to March 2024 and as a content manager and photographer at Cube in January 2019. Barbara's extensive experience includes significant roles at the European Medicines Agency and the Austrian Agency for Health and Food Safety, where responsibilities encompassed regulatory affairs, toxicology, and preclinical assessment. Barbara's earlier positions included senior roles at Novartis and research posts focused on molecular biology and oral tolerance. Academic credentials include an MSc in Toxicology from the Medical University of Vienna and veterinary education from Vetmeduni.